Edwards Lifesciences Corporatio (NYSE:EW)

Tuesday, February 3, 2009 | Web News
Guidance Report: (Non-China) Full Year Fiscal 2009 Guidance Ending December > EPS Figures exclude non-operating gains and losses (Non-GAAP)...
See All Research...

Edwards Lifesciences Corporation (Edwards Lifesciences), incorporated on September 10, 1999, is engaged in the science of heart valves and hemodynamic monitoring. The products and technologies provided by Edwards Lifesciences to treat advanced cardiovascular disease or critically ill patients are categorized into four main areas: Heart Valve Therapy; Critical Care; Cardiac Surgery Systems, and Vascular. Patients undergoing surgical treatment for cardiovascular disease may be treated using a range of Edwards Lifesciences products and technologies. In March 2011, the Company completed the acquisition of Embrella Cardiovascular, Inc.

Web site: http://www.edwards.com

Last updated July 31, 2012